MedTrace Logo

Cross-cultural Adaptation and Validation of the CISS and the PWES Questionnaire in Patients With Hand Pathologies.

NCT04646343 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2024-08-29

No results posted yet for this study

Summary

The primary objective of the study is to do translation, cross-cultural adaptation and validation of the CISS and PWES questionnaire in French. No available translation exist in French.

In the first part of the study, the investigators will use clinical guidelines for translation and cross-cultural adaptation of questionnaire (Beaton and al).The content validity will be evaluated also in this first step.

In the second part of the study the French version of CISS and PWES (F-CISS and F-PWES) will be validated. Different psychometric properties (internal consistency, test retest reliability, construct validity, floor and ceiling effects) will be study. The investigators use the recommendation of COSMIN (COnsensus- based Standards for the selection of health Measurement INstruments) group.

Conditions

  • Hand Injuries and Disorders

Interventions

OTHER

administration of F-CISS and F-PWES pre version

the CISS questionnaire is a 6 items questionnaire, the PWES is a 3 items questionnaire. Only 10 minutes are required to fulfilled the questionnaires.

OTHER

administration of definitive version of F-CISS and F-PWES plus F-DASH, F-HFS and F-SF 36

The administration will required 25 minutes

Sponsors & Collaborators

  • Clinique Romande de Readaptation

    lead NETWORK

Principal Investigators

  • Bertrand Léger, PhD · institut de recherche en réadaptatation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2023-08-31
Completion
2024-08-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04646343 on ClinicalTrials.gov